| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |